Kamunting Street Capital Management, L.P. Vertex Pharmaceuticals Inc Call Options Transaction History

Kamunting Street Capital Management, L.P.

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $2.27 Million - $2.54 Million	-12,500 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $2.34 Million - $2.76 Million	12,500 New	12,500 $2.52 Million

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Kamunting Street Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Kamunting Street Capital Management, L.P. with notifications on news.